Published in Transplantation on August 27, 2010
Racial variation in medical outcomes among living kidney donors. N Engl J Med (2010) 3.60
A prospective controlled study of kidney donors: baseline and 6-month follow-up. Am J Kidney Dis (2013) 1.55
Consistency of racial variation in medical outcomes among publicly and privately insured living kidney donors. Transplantation (2014) 1.22
Risks and outcomes of living donation. Adv Chronic Kidney Dis (2012) 1.12
Long-term medical risks to the living kidney donor. Nat Rev Nephrol (2015) 1.00
The unjustified classification of kidney donors as patients with CKD: critique and recommendations. Clin J Am Soc Nephrol (2013) 0.95
Low nephron number and its clinical consequences. Rambam Maimonides Med J (2011) 0.85
The Impact of Kidney Development on the Life Course: A Consensus Document for Action. Nephron (2017) 0.82
Young aboriginals are less likely to receive a renal transplant: a Canadian national study. BMC Nephrol (2013) 0.79
Mass screening for chronic kidney disease in rural and remote Canadian first nations people: methodology and demographic characteristics. Can J Kidney Health Dis (2015) 0.75
Cardiovascular disease in kidney donors: matched cohort study. BMJ (2012) 5.00
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant (2001) 1.88
Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation (2008) 1.83
Urinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypass. Clin J Am Soc Nephrol (2011) 1.75
Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol (2004) 1.67
Informing the debate: rates of kidney transplantation in nations with presumed consent. Ann Intern Med (2010) 1.65
Acute dialysis risk in living kidney donors. Nephrol Dial Transplant (2012) 1.60
Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol (2003) 1.45
Canadian Society of Nephrology commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis (2013) 1.44
Antibody-mediated rejection: analyzing the risk, proposing solutions. Transplantation (2014) 1.44
Biologically variable bypass reduces enzymuria after deep hypothermic circulatory arrest. Ann Thorac Surg (2006) 1.41
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup. Clin Cancer Res (2002) 1.24
Serum creatinine measurement immediately after cardiac surgery and prediction of acute kidney injury. Am J Kidney Dis (2011) 1.22
Functional gene polymorphisms in canadian aboriginal populations with high rates of tuberculosis. J Infect Dis (2008) 1.06
Fracture risk in living kidney donors: a matched cohort study. Am J Kidney Dis (2012) 1.06
Over-expression of a cacao class I chitinase gene in Theobroma cacao L. enhances resistance against the pathogen, Colletotrichum gloeosporioides. Planta (2005) 1.05
Evolution of HLA antibody detection: technology emulating biology. Immunol Res (2004) 1.05
Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. Transplantation (2003) 0.94
Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Kidney Dis (2010) 0.93
Validation of urinary CXCL10 as a marker of borderline, subclinical, and clinical tubulitis. Transplantation (2011) 0.93
Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent. Am J Physiol Heart Circ Physiol (2002) 0.92
Renal oxygenation in acute renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2014) 0.90
Reproducibility of the Banff classification in subclinical kidney transplant rejection. Clin Transplant (2005) 0.90
FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Mod Pathol (2013) 0.90
Clinical Trials for Immunosuppression in Transplantation; The Case for Reform and Change in Direction. Transplantation (2017) 0.87
FRAX predicts fracture risk in kidney transplant recipients. Transplantation (2014) 0.86
Immune monitoring of kidney allografts. Am J Kidney Dis (2012) 0.85
Regular physical activity and exercise therapy in end-stage renal disease: how should we move forward? J Nephrol (2010) 0.85
Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation. Transplantation (2015) 0.84
Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil. Transplantation (2009) 0.84
Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohort. PLoS One (2012) 0.83
Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts. Transplantation (2010) 0.81
Proteomic characterization of serine hydrolase activity and composition in normal urine. Clin Proteomics (2013) 0.81
Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months. Transplantation (2014) 0.81
Attitudes to sharing personal health information in living kidney donation. Clin J Am Soc Nephrol (2010) 0.79
Hemodialysis in a satellite unit: clinical performance target attainment and health-related quality of life. Clin J Am Soc Nephrol (2011) 0.78
Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss. Transplantation (2013) 0.78
Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: study protocol for a randomized controlled trial. Trials (2013) 0.78
Validity of physician billing claims to identify deceased organ donors in large healthcare databases. PLoS One (2013) 0.78
Elevated Urinary Matrix Metalloproteinase-7 Detects Underlying Renal Allograft Inflammation and Injury. Transplantation (2016) 0.78
Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade. Am J Kidney Dis (2005) 0.78
Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome. Transplantation (2016) 0.77
Long-term changes in bone mineral density in kidney transplant recipients. Transplantation (2014) 0.77
Living donor age and kidney transplant outcomes: an assessment of risk across the age continuum. Transpl Int (2013) 0.77
Cardiovascular disease after Escherichia coli O157:H7 gastroenteritis. CMAJ (2012) 0.76
Protocol biopsies should be standard of care for pediatric renal allograft recipients! Pediatr Transplant (2006) 0.76
Urinary biomarkers of renal transplant outcome. Curr Opin Organ Transplant (2015) 0.76
Urinary biomarkers in acute kidney injury: ready for prime time? Am J Kidney Dis (2010) 0.75
It's about time: extending our understanding of cardiovascular risk from chronic kidney disease. J Am Soc Nephrol (2009) 0.75
Urinary metabolomics for noninvasive detection of antibody-mediated rejection in children after kidney transplantation. Transplantation (2017) 0.75
Troponin I testing in dialysis patients presenting to the emergency room: does troponin I predict the 30-day outcome? Nephron Clin Pract (2006) 0.75
Subclinical Antibody-Mediated Rejection. Transplantation (2017) 0.75
ANCA Associated Vasculitis Secondary to Levamisole-Adultered Cocaine with Associated Membranous Nephropathy: A Case Series. Am J Nephrol (2017) 0.75